Mealey's (November 20, 2018, 12:20 PM EST) -- ST. LOUIS — In challenges to the consolidation of 22 ovarian cancer cases and admission of expert testimony linking asbestos and talc to the women’s diseases, Johnson & Johnson simply rehashes previously rejected arguments, plaintiffs told a St. Louis court Oct. 31 in arguing that the evidence of plaintiff suffering and the company’s reprehensible conduct support the $4.69 billion verdict (Gail Ingham, et al. v. Johnson & Johnson, et al., No. 1522-CC-10417, Mo. Cir., St. Louis Co.)....